Streetbeat News

Stock Prices

ALT

AMGN

LLY

NVO

PFE

Novo Nordisk and Eli Lilly, leaders in the obesity drug market, may face competition from 16 new drugs expected by 2029. Despite their current dominance, new entrants like Roche, Pfizer, and Amgen could shift market dynamics. Analysts suggest Novo and Lilly stocks might be overvalued due to potential market changes.

Portfolio Pulse from Vandana Singh

October 11, 2024 | 6:11 pm

CLSK

COIN

RIOT

CleanSpark shares are rising due to an increase in Bitcoin's price. The company recently announced a significant increase in its operational hashrate and a new Chief Accounting Officer. Other crypto-linked stocks like Coinbase and Riot Platforms are also seeing gains.

Portfolio Pulse from Dylan Berman

October 11, 2024 | 6:10 pm

LNG

MPWR

MSTR

NEE

TMO

Benzinga's Stock Whisper Index highlights five stocks that are gaining interest among investors: NextEra Energy, Monolithic Power Systems, MicroStrategy, Cheniere Energy, and Thermo Fisher Scientific. These stocks are being monitored due to recent events, analyst ratings, and upcoming earnings reports.

Portfolio Pulse from Chris Katje

October 11, 2024 | 6:06 pm

OKTA

Wealthy investors are showing interest in Okta (NASDAQ:OKTA) with a mix of bullish and bearish options trades. The majority of trades are calls, indicating a bullish sentiment. The targeted price range is $70 to $82.5. Okta's stock is currently priced at $78.25, with a slight increase of 0.41%.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:04 pm

BOOM

In the past three months, analysts have shown a range of sentiments towards DMC Global Inc (NASDAQ:BOOM), with a recent decrease in the average price target by 9.52%. The company's financial metrics reveal challenges in revenue growth but strong profitability and financial management.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:01 pm

TIGR

UP Fintech Holding (NASDAQ:TIGR) has significantly outperformed the market over the past decade, delivering an average annual return of 32.01%. A $100 investment in TIGR 10 years ago would be worth $1,700 today. The article highlights the power of compounded returns over time.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

MDB

In the past three months, 17 analysts have shared their evaluations of MongoDB (NASDAQ:MDB), with a mix of bullish and somewhat bullish ratings. The average 12-month price target has increased by 9.96% to $335.88. Analysts have raised their price targets, reflecting positive sentiment towards MongoDB's market position despite challenges in profitability and growth compared to industry averages.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

TMHC

Taylor Morrison Home (NYSE:TMHC) has outperformed the market over the past 5 years, achieving an average annual return of 20.59%. A $100 investment in TMHC 5 years ago would now be worth $261.13, highlighting the power of compounded returns.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

UBER

Analysts' ratings for Uber Technologies (NYSE:UBER) show a mix of bullish and somewhat bullish sentiments, with an average 12-month price target of $89.14, up 2.13% from the previous target. Analysts have maintained or raised their ratings, reflecting positive sentiment towards Uber's financial health, including strong revenue growth and profitability metrics.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm

ADUS

Addus HomeCare (NASDAQ:ADUS) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. Analysts have set a 12-month average price target of $141.56, reflecting a 4.56% increase from the previous target. The company's financial performance shows strong revenue growth and profitability, with a notable net margin and return on equity.

Portfolio Pulse from Benzinga Insights

October 11, 2024 | 6:00 pm